Literature DB >> 20187999

The soyabean isoflavone genistein modulates endothelial cell behaviour.

Marisa J Sandoval1, Pablo H Cutini, María Belén Rauschemberger, Virginia L Massheimer.   

Abstract

The aim of the present study was to investigate the direct action of the phyto-oestrogen genistein (Gen) on vascular endothelial behaviour, either in the presence or absence of proinflammatory agents. In rat aortic endothelial cell (EC) cultures, 24 h of treatment with Gen significantly increased cell proliferation in a wide range of concentration (0.001-10 nm). This mitogenic action was prevented by the oestrogen receptor (ER) antagonist ICI 182780 or by the presence of the specific NO synthase inhibitor l-nitro-arginine methyl ester. When monocytes adhesion to EC was measured, Gen partially attenuated leucocyte adhesion not only under basal conditions, but also in the presence of bacterial lipopolysaccharides (LPS). The effect of the phyto-oestrogen on the expression of EC adhesion molecules was evaluated. Gen down-regulated the enhancement in mRNA levels of E-selectin, vascular cell adhesion molecule-1 and P-selectin elicited by the proinflammatory agent bacterial LPS. The regulation of EC programmed death induced by the isoflavone was also demonstrated. Incubation with 10 nm Gen prevented DNA fragmentation induced by the apoptosis inductor H2O2. The results presented suggest that Gen would exert a protective effect on vascular endothelium, due to its regulatory action on endothelial proliferation, apoptosis and leucocyte adhesion, events that play a critical role in vascular diseases. The molecular mechanism displayed by the phyto-oestrogen involved the participation of the ER and the activation of the NO pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20187999     DOI: 10.1017/S0007114510000413

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  6 in total

Review 1.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

2.  Protective effects of 7-difluoromethyl-5,4'-dimethoxygenistein against human aorta endothelial injury caused by lysophosphatidyl choline.

Authors:  Fei Liu; Jian-Guo Cao; Cheng Li; Jin-Seng Tan; Xiao-Hua Fu
Journal:  Mol Cell Biochem       Date:  2011-12-24       Impact factor: 3.396

3.  Genistein Protects Against Ox-LDL-Induced Inflammation Through MicroRNA-155/SOCS1-Mediated Repression of NF-ĸB Signaling Pathway in HUVECs.

Authors:  Huaping Zhang; Zhenxiang Zhao; Xuefen Pang; Jian Yang; Haixia Yu; Yinhong Zhang; Hui Zhou; Jiahui Zhao
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

4.  The isoflavone genistein enhances osteoblastogenesis: signaling pathways involved.

Authors:  Sabrina B Cepeda; Marisa J Sandoval; María Carla Crescitelli; María Belén Rauschemberger; Virginia L Massheimer
Journal:  J Physiol Biochem       Date:  2020-01-02       Impact factor: 4.158

5.  Genistein inhibits cell invasion and motility by inducing cell differentiation in murine osteosarcoma cell line LM8.

Authors:  Atsushi Nakamura; Junichi Aizawa; Kenshi Sakayama; Teruki Kidani; Tomoyo Takata; Yoshiaki Norimatsu; Hiromasa Miura; Hiroshi Masuno
Journal:  BMC Cell Biol       Date:  2012-09-26       Impact factor: 4.241

6.  Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women.

Authors:  Veronika A Myasoedova; Tatyana V Kirichenko; Alexandra A Melnichenko; Varvara A Orekhova; Alessio Ravani; Paolo Poggio; Igor A Sobenin; Yuri V Bobryshev; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.